Roche Holding AG (XSWX:ROG) Buildings And Improvements

: CHF19,886 Mil (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

Roche Holding AG's quarterly buildings and improvements declined from Dec. 2022 (CHF21,349 Mil) to Jun. 2023 (CHF0 Mil) but then increased from Jun. 2023 (CHF0 Mil) to Dec. 2023 (CHF19,886 Mil).

Roche Holding AG's annual buildings and improvements increased from Dec. 2021 (CHF19,215 Mil) to Dec. 2022 (CHF21,349 Mil) but then declined from Dec. 2022 (CHF21,349 Mil) to Dec. 2023 (CHF19,886 Mil).

Roche Holding AG Buildings And Improvements Historical Data

The historical data trend for Roche Holding AG's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buildings And Improvements

17,353.00

18,360.00

19,215.00

21,349.00

19,886.00

Roche Holding AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Buildings And Improvements																19,215.00	-	21,349.00	-	19,886.00

Roche Holding AG Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Roche Holding AG (XSWX:ROG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (XSWX:ROG) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

RHHVF:USA RHHBY:USA RHHBF:USA ROG N:Mexico ROz:UK ROGz:UK 0QOK:UK RHO6:Germany RO:Switzerland

Address

Grenzacherstrasse 124, Basel, CHE, 4070

Website

https://www.roche.com

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.